Difference between revisions of "NextGen-O2k Exploitation"
From Bioblast
Beno Marija (talk | contribs) |
Beno Marija (talk | contribs) |
||
| Line 26: | Line 26: | ||
<br/> | <br/> | ||
<gallery mode=default perrow=4 widths="350px" heights="300px"> | <gallery mode=default perrow=4 widths="350px" heights="300px"> | ||
File:ASMRM2021.JPG | File:ASMRM2021.JPG|Snapshot of the J-Mit and ASMRM 2019 | ||
File:JP Onsite.jpg | File:JP Onsite.jpg|On-site visit in Japan | ||
File:ORODM1A.jpg | File:ORODM1A.jpg|The first Distributor Meeting | ||
|- | |- | ||
</gallery> | </gallery> | ||
Revision as of 15:24, 11 March 2020
Template:MitoFit highlights page name
The revolutionary all-in-one instrument to conquer mitochondrial disease.
WP4: Exploitation
Abstract
- Preparation for a successful market launch of the NextGen-O2k.
Progress and next steps
- 2020-02-04: Our Mitochondrial Wizard Luiza Daltro Cardoso, PhD went to Japan to meet our distributor and teach him high-resolution respirometry combined with H2O2, mt-membrane potential and ATP production measurements: Distributor engagement Tokyo JP
- 2020-10-03: Erich Gnaiger travels to Fukuoka to attend J-Mit and ASMRM 2019 and meet our distributor Berthold Japan K.K.
- 2019-07-01: The first Distributor Meeting took place, see more: Oroboros Distributor Meeting
Snapshot of the J-Mit and ASMRM 2019
On-site visit in Japan
The first Distributor Meeting
